Īrija - angļu - HPRA (Health Products Regulatory Authority)

hayes, conyngham & robinson ltd - liquorice liquid extract ipecacuanha fluid extract - oral solution

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

john s hayes & associates pty ltd -

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

john s hayes & associates pty ltd -

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

john s hayes & associates pty ltd -

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

miro healthcare limited - amoxicillin trihydrate 287.5mg equivalent to amoxicillin 250 mg;  ;   - capsule - 250 mg - active: amoxicillin trihydrate 287.5mg equivalent to amoxicillin 250 mg     excipient: brilliant blue fcf carmoisine croscarmellose sodium gelatin ink magnesium stearate methyl hydroxybenzoate propyl hydroxybenzoate purified water quinoline yellow sodium laurilsulfate sunset yellow fcf   titanium dioxide   - amoxicillin is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms: upper respiratory infections: otitis media, pharyngitis, sinusitis and tonsillitis. lower respiratory infections: bronchitis, bronchopneumonia and lobar pneumonia. urinary tract infections: cystitis, cysto-pyelitis, urethritis, and gonococcal urethritis. prophylaxis: against ?-haemolytic (viridans group) and ?-haemolytic streptococci before dental, oral or upper respiratory tract surgery or instrumentation. prophylaxis: of bacterial endocarditis in patients with any of the following conditions: congenital cardiac malformations, rheumatic and other acquired valvular lesions, prosthetic heart valves, previous history of bacterial endocarditis, hypertrophic cardiomyopathy, surgically constructed systemic-pulmonary shunts, mitral valve prolapse with valvular regurgitation or mitral valve prolapse without valvular regurgitation but associated with thickening and/or redundancy of the valve leaflets. amoxicillin is further indicated for the treatment of cutaneous infections. in emergency cases where the causative organism is not yet identified, therapy may be initiated with amoxicillin on the basis of clinical judgement, while awaiting the results of bacteriologic studies to determine its antimicrobial sensitivity.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

miro healthcare limited - amoxicillin trihydrate 575mg equivalent to amoxicillin 500 mg;  ;   - capsule - 500 mg - active: amoxicillin trihydrate 575mg equivalent to amoxicillin 500 mg     excipient: brilliant blue fcf carmoisine croscarmellose sodium gelatin ink magnesium stearate methyl hydroxybenzoate propyl hydroxybenzoate purified water quinoline yellow sodium laurilsulfate sunset yellow fcf   titanium dioxide   - amoxicillin is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms: upper respiratory infections: otitis media, pharyngitis, sinusitis and tonsillitis. lower respiratory infections: bronchitis, bronchopneumonia and lobar pneumonia. urinary tract infections: cystitis, cysto-pyelitis, urethritis, and gonococcal urethritis. prophylaxis: against ?-haemolytic (viridans group) and ?-haemolytic streptococci before dental, oral or upper respiratory tract surgery or instrumentation. prophylaxis: of bacterial endocarditis in patients with any of the following conditions: congenital cardiac malformations, rheumatic and other acquired valvular lesions, prosthetic heart valves, previous history of bacterial endocarditis, hypertrophic cardiomyopathy, surgically constructed systemic-pulmonary shunts, mitral valve prolapse with valvular regurgitation or mitral valve prolapse without valvular regurgitation but associated with thickening and/or redundancy of the valve leaflets. amoxicillin is further indicated for the treatment of cutaneous infections. in emergency cases where the causative organism is not yet identified, therapy may be initiated with amoxicillin on the basis of clinical judgement, while awaiting the results of bacteriologic studies to determine its antimicrobial sensitivity.

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

sun pharma uk ltd - amoxicillin trihydrate; potassium clavulanate - oral tablet - 500mg ; 125mg

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

sun pharma uk ltd - celiprolol hydrochloride - oral tablet - 200mg

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

sun pharma uk ltd - celiprolol hydrochloride - oral tablet - 400mg

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

ranbaxy (uk - loratadine - tablet - 10mg